GEN Exclusives

More »

GEN News Highlights

More »
Nov 10, 2006

Octoplus Begins Doubling of Facilities

  • OctoPlus has begun construction work to more than double its facilities. “The expansion is necessary to support clinical development for the company’s own products and to facilitate the growing demand for the company’s services,” says Joost Holthuis, CEO.

    The company’s existing facilities comprise offices, laboratories, and a GMP manufacturing plant that produces clinical-scale GMP batches for the development of OctoPlus’ own products and for its formulation development customers.

    The new facilities will bring the current 2,800-sq-m building to a combined total of 6,300-sq-m. The company plans to move into the building toward the end of 2007.

    The building will be constructed and owned by Fortress Participations, which will lease it to OctoPlus, which, in turn, will invest in research equipment and GMP production equipment to operate the facilities. It will be located adjacent to OctoPlus’ headquarters in the Bio Science Park in Leiden, The Netherlands.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »